These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3944711)

  • 1. Low risk of hepatitis B from blood transfusions in thalassemic patients in Connecticut.
    Pearson HA; Wood C; Andiman W; Bove J; Rink L
    J Pediatr; 1986 Feb; 108(2):252-3. PubMed ID: 3944711
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.
    Papaevangelou G; Frösner G; Economidou J; Parcha S; Roumeliotou A
    Br Med J; 1978 Mar; 1(6114):689-91. PubMed ID: 630296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.
    Moroni GA; Piacentini G; Terzoli S; Jean G; Masera G
    Arch Dis Child; 1984 Dec; 59(12):1127-30. PubMed ID: 6441522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.
    Choudhry VP; Acharya SK
    Indian J Pediatr; 1995; 62(6):655-68. PubMed ID: 10829940
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
    Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
    Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
    Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
    [No Abstract]   [Full Text] [Related]  

  • 9. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 11. The dangerous outcomes of blood transfusion to thalassemia patients in Pakistan.
    Shah DA
    J Infect Public Health; 2015; 8(5):510-1. PubMed ID: 25731675
    [No Abstract]   [Full Text] [Related]  

  • 12. Transmission of hepatitis B virus by blood transfusion in Yaounde, Cameroon.
    Ndumbe PM; Nyouma E
    BMJ; 1990 Sep; 301(6751):523-4. PubMed ID: 2207420
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B in household contacts of children with beta-thalassemia.
    Papanastasiou DA; Spiliopoulou IT; Papageorgiou OG; Beratis NG
    Acta Haematol; 1990; 84(4):182-5. PubMed ID: 2125782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of hepatitis B virus by HBV-negative blood transfusion.
    Elghouzzi MH; Couroucé AM; Magnius LO; Lunel F; Lapierre V
    Lancet; 1995 Oct; 346(8980):964. PubMed ID: 7564744
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factors.
    Atwa ZT; Abdel Wahed WY
    J Infect Public Health; 2017; 10(6):870-874. PubMed ID: 28292647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A follow-up investigation of 12 blood transfusion cases from HBsAg-positive donors].
    Li FS; Yan Y; Pan NS
    Zhonghua Nei Ke Za Zhi; 1986 Jul; 25(7):407-8, 444-5. PubMed ID: 3803056
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up.
    Ocak S; Kaya H; Cetin M; Gali E; Ozturk M
    Arch Med Res; 2006 Oct; 37(7):895-8. PubMed ID: 16971232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.
    Shah T; Hussain W; Ali N; Sardar S; Ishaq M; Ur Rahman M; Ding L; Qayyum S; Khan I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):248-252. PubMed ID: 30358571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The epidemiologic role of donors who are long-term carriers of the Australian antigen].
    Golosova TV; Kasavina MA; Margolina AN; Kantorovich RA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):102-5. PubMed ID: 4454805
    [No Abstract]   [Full Text] [Related]  

  • 20. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.